Jim Zapf
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$1.1MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $1.1M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 24, 2021 | NIH | SBIR Phase I Development of inhibitors of the SGK1 kinase, a critical target in anaplastic thyroid cancer | $86K | VISIONARY PHARMACEUTICALS, INC. |
| Sep 12, 2019 | NIH | SBIR Phase I Development of dual inhibitors of the kinases SGK1 and AKT1 for blockade of a critical pathway in triple-negative breast cancer | $300K | VISIONARY PHARMACEUTICALS, INC. |
| Aug 1, 2019 | NIH | SBIR Phase I Development of inhibitors of the SGK1 kinase, a critical target in anaplastic thyroid cancer | $300K | VISIONARY PHARMACEUTICALS, INC. |
| Jun 15, 2017 | NIH | SBIR Phase I Identification of RORg drug candidates for the treatment of NASH | $157K | VISIONARY PHARMACEUTICALS, INC. |
| Sep 9, 2016 | NIH | SBIR Phase I Identification of RORg drug candidates for the treatment of NASH | $300K | VISIONARY PHARMACEUTICALS, INC. |
Peer ranks
Federal funding#1,637
Awards as PI#417
Patents#273
Companies
- VISIONARY PHARMACEUTICALS, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.